A CASE SERIES OF LONGER THAN EXPECTED SURVIVAL IN IDH-WILDTYPE, MGMT-UNMETHYLATED GLIOBLASTOMA PATIENTS

被引：0
|
作者：
Lomax, Jerica [1 ]
Kong, Xiao-Tang [2 ]
Bota, Daniela [3 ]
机构：
[1] Univ Calif Irvine, Orange, CA 92668 USA
[2] UC Irvine, Irvine, CA USA
[3] Univ Calif Irvine, Irvine, CA USA
来源：
NEURO-ONCOLOGY | 2023年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PATH-24
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Partial resection offers an overall survival benefit over biopsy in MGMT-unmethylated IDH-wildtype glioblastoma patients
    Hallaert, Giorgio
    Pinson, Harry
    Vanhauwaert, Dimitri
    Van den Broecke, Caroline
    Van Roost, Dirk
    Boterberg, Tom
    Kalala, Jean-Pierre
    SURGICAL ONCOLOGY-OXFORD, 2020, 35 : 515 - 519
  • [2] 18F-DOPA PET/CT SURVEILLANCE FOR GLIOBLASTOMA: A RADIOMIC MODEL FROM A PROSPECTIVE PHASE II CLINICAL TRIAL PREDICTING SURVIVAL IN IDH-WILDTYPE, MGMT-UNMETHYLATED PATIENTS
    Qian, Jing
    Pafundi, Deanna
    Breen, William
    Brown, Paul
    Hunt, Christopher
    Jacobson, Mark
    Johnson, Derek
    Kaufmann, Timothy
    Kemp, Bradley
    Kizilbash, Sani
    Lowe, Val
    Ruff, Michael
    Sarkaria, Jann
    Uhm, Joon
    Tseung, Hok Seum Wan Chan
    Yan, Elizabeth
    Zhang, Yan
    Laack, Nadia
    Brinkmann, Debra
    NEURO-ONCOLOGY, 2022, 24 : 52 - 52
  • [3] Impact of frailty on survival glioblastoma, IDH-wildtype patients
    Hudelist, Benoit
    Elia, Angela
    Roux, Alexandre
    Paun, Luca
    Schumacher, Xavier
    Hamza, Meissa
    Demasi, Marco
    Moiraghi, Alessandro
    Dezamis, Edouard
    Chretien, Fabrice
    Benzakoun, Joseph
    Oppenheim, Catherine
    Zanello, Marc
    Pallud, Johan
    JOURNAL OF NEURO-ONCOLOGY, 2024, 169 (01) : 61 - 72
  • [4] Levetiracetam offers a survival advantage in patients with epilepsy related to MGMT-unmethylated glioblastoma
    Rojas, L.
    Ruiz-Patino, A.
    Cardona, A. F.
    Arrieta, O.
    Zatarain-Barron, Z.
    ANNALS OF ONCOLOGY, 2017, 28
  • [5] THE PROGNOSTIC AND PREDICTIVE SIGNIFICANCE OF PARTIAL MGMT PROMOTER METHYLATION FOR IDH-WILDTYPE GLIOBLASTOMA PATIENTS
    Torre, Matthew
    Iorgulescu, Bryan
    NEURO-ONCOLOGY, 2022, 24 : 10 - 10
  • [6] Role of postoperative tumor volume in patients with MGMT-unmethylated glioblastoma
    Arthur H. A. Sales
    Stefanie Bette
    Melanie Barz
    Thomas Huber
    Benedikt Wiestler
    Yu-Mi Ryang
    Friederike Schmidt-Graf
    Friederike Liesche
    Stephanie E. Combs
    Bernhard Meyer
    Jens Gempt
    Journal of Neuro-Oncology, 2019, 142 : 529 - 536
  • [7] Role of postoperative tumor volume in patients with MGMT-unmethylated glioblastoma
    Sales, Arthur H. A.
    Bette, Stefanie
    Barz, Melanie
    Huber, Thomas
    Wiestler, Benedikt
    Ryang, Yu-Mi
    Schmidt-Graf, Friederike
    Liesche, Friederike
    Combs, Stephanie E.
    Meyer, Bernhard
    Gempt, Jens
    JOURNAL OF NEURO-ONCOLOGY, 2019, 142 (03) : 529 - 536
  • [8] Does positive MGMT methylation outbalance the limitation of subtotal resection in glioblastoma IDH-wildtype patients?
    Müller Mareike
    Staub-Bartelt Franziska
    Ehrmann Julia
    Hänggi Daniel
    Sabel Michael
    Felsberg Jörg
    Rapp Marion
    Journal of Neuro-Oncology, 2021, 153 : 537 - 545
  • [9] The Association Between the Extent of Glioblastoma Resection and Survival in Light of MGMT Promoter Methylation in 326 Patients With Newly Diagnosed IDH-Wildtype Glioblastoma
    Incekara, Fatih
    Smits, Marion
    van der Voort, Sebastian R.
    Dubbink, Hendrik Jan
    Atmodimedjo, Peggy N.
    Kros, Johan M.
    Vincent, Arnaud J. P. E.
    van den Bent, Martin
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [10] Does positive MGMT methylation outbalance the limitation of subtotal resection in glioblastoma IDH-wildtype patients?
    Mareike, Mueller
    Franziska, Staub-Bartelt
    Julia, Ehrmann
    Daniel, Haenggi
    Michael, Sabel
    Joerg, Felsberg
    Marion, Rapp
    JOURNAL OF NEURO-ONCOLOGY, 2021, 153 (03) : 537 - 545
12345